SCHEMBL3883149

SCHEMBL3883149

CC(C)CCNCc1ccc(Cn2ccc3cc(OC(N)=O)ccc32)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC6 Q9UBN7 9/20 0.47
HDAC8 Q9BY41 8/20 0.47
HDAC11 Q96DB2 2/20 0.47
THRA P10827 1/20 0.45
THRB P10828 1/20 0.45
HDAC3 O15379 7/20 0.45
HDAC1 Q13547 7/20 0.45
HDAC2 Q92769 7/20 0.45
HDAC10 Q969S8 5/20 0.45
HDAC4 P56524 1/20 0.42
HDAC7 Q8WUI4 1/20 0.42
HDAC9 Q9UKV0 1/20 0.42
HDAC5 Q9UQL6 1/20 0.42
NCOR2 Q9Y618 1/20 0.42
PLG P00747 1/20 0.41
PLAU P00749 1/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
MTNR1A P48039 1/20 0.40
MTNR1B P49286 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL220038 0.84 PLAU (0.52) HDAC6HDAC8HDAC11HDAC3HDAC1
SCHEMBL218188 0.82 PLG (0.49) HDAC6HDAC8HDAC11HDAC3HDAC1
SCHEMBL3891015 0.75 OPRM1 (0.52) HDAC6HDAC8HDAC11HDAC3HDAC1
SCHEMBL219690 0.73 HDAC6 (0.60) HDAC6HDAC8HDAC11HDAC3HDAC1
SCHEMBL4966876 0.72 ALDH1A1 (0.44) MEN1KMT2AOPRM1OPRD1OPRK1
SCHEMBL4965646 0.70 OPRM1 (0.41) HDAC1MEN1KMT2AOPRM1OPRD1
SCHEMBL220311 0.70 PLAU (0.52) HDAC6HDAC8HDAC11HDAC3HDAC1
Hydrochloric Acid SCHEMBL4965277 0.69 OPRM1 (0.41) HDAC1MEN1KMT2AOPRM1OPRD1
SCHEMBL28562747 0.69 HDAC6 (0.64) HDAC6HDAC8HDAC11THRATHRB
SCHEMBL30185502 0.69 HDAC6 (0.64) HDAC6HDAC8HDAC11THRATHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1751103-B1 4-(5-(AMINOMETHYL)-INDOLE-1-YLMETHYL)-BENZAMIDE DERIVATIVES AND RELATED COMPOUNDS AS OPIOID RECEPTOR ANTAGONISTS FOR THE TREATMENT OF OBESITY LILLY CO ELI (US) 2009-01-14 EP claimed